Diuretic of Choice in ABFM Hypertension Self-Assessment Module Simulations

References

1. 1.↵
   National Heart, Lung, and Blood Institute. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation , and Treatment of High Blood Pressure. Available at http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm. Accessed November 17, 2011.
2. 2.↵
   1. Messerli FH,
   2. Bangalore S

   . Half a century of hydrochlorothiazide: facts, fads, fiction, and follies. Am J Med 2011;124:896–9.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Dorsch MP,
   2. Gillespie BW,
   3. Erickson SR,
   4. Bleske BE,
   5. Weder AB

   . Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011;57:689–94.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Ernst ME,
   2. Carter BL

   . Renewed interest in chlorthalidone: evidence from the Veterans Health Administration. J Clin Hyperten 2010;12:927–34.

   OpenUrl
5. 5.↵
   1. Ernst ME,
   2. Carter BL,
   3. Zheng S,
   4. Grimm RH

   . Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens 2010;23:440–6.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Al Badarin FJ,
   2. Abuannadi MA,
   3. Lavie CJ,
   4. O'Keefe JH

   . Evidence-based diuretic therapy for improving cardiovascular prognosis in systemic hypertension. Am J Cardiol 2011;107:1178–84.

   OpenUrlPubMed
7. 7.↵
   1. Taler SJ

   . Should chlorthalidone be the diuretic of choice for antihypertensive therapy?. Curr Hypertens Rep 2008;10:293–7.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Hagen MD,
   2. Ivins D,
   3. Puffer JC,
   4. et al

   . Maintenance of certification for family physicians (MC-FP) self-assessment modules (SAMs): the first year. J Am Board Fam Med 2006;19:398–403.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Haines A,
   2. Jones R

   . Implementing findings of research. BMJ 1994;308:1488–92.

   OpenUrlFREE Full Text
10. 10.↵
    1. Ernst ME,
    2. Neaton JD,
    3. Grimm RH Jr.,
    4. et al

    ; Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the multiple risk factor intervention trial. Hypertension 2011;58:1001–7.

    OpenUrl
11. 11.↵
    Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991;265:3255–64.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group. Arch Intern Med 1991;151:1413–23.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981–97.

    OpenUrl
14. 14.↵
    1. Ernst ME,
    2. Carter BL,
    3. Goerdt CJ,
    4. et al

    . Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352–8.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Kostis JB,
    2. Cabrera J,
    3. Cheng JQ,
    4. et al

    . Association between chlorthalidone treatment of systolic hypertension and long-term survival. JAMA 2011;306:2588–93.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Carter BL,
    2. Ernst ME,
    3. Cohen JD

    . Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4–9.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Wiysonge CS,
    2. Bradley HA,
    3. Volmink J,
    4. Mayosi BM,
    5. Mbewu A,
    6. Opie LH

    . Beta-blockers for hypertension. Cochrane Database Syst Rev 2007;8:CD002003.

    OpenUrl
18. 18.↵
    1. Franse LV,
    2. Pahor M,
    3. Di Bari M,
    4. Somes GW,
    5. Cuhsman WC,
    6. Applegate WB

    . Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension 2000;35:1025–30.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Sumner W 2nd.,
    2. O'Neill TR,
    3. Roussel G,
    4. et al

    . Family physicians' completion of scoring criteria in virtual patient encounters. AMIA Annu Symp Proc 2011;2011:1355–60.

    OpenUrlPubMed